In this way, using an established in vitro model of lipotoxicity in HepG2 cells, as well as an animal model of fatty liver, the enzyme ACC-1 was identified at the serum level using the ELISA technique during the early stages of cellular and tissue damage, such as necrosis and fibrosis, respectively. This evidence concerns the gene ACACA and fatty liver disease.